Antitumor and Immunopotentiating Activity of Polysaccharide PST001 Isolated from the Seed Kernel of Tamarindus indica: An In Vivo Study in Mice
Table 3
Tumor and hematological characteristics in mice injected with drug for 7 days, DLA administered on 8th day, observed for 21 days, and dissected on 22nd day (Group 4).
Concentration
DLA control
PST 200 mg/kg
CTX 50 mg/kg
PST + CTX
Tumor volume (mL)
9 ± 0.5
4 ± 0.61***
***
***
Body weight (g)
*
**
**
PCV (mL)
***
***
**
Mean survival time (Days)
23 ± 0.87
38 ± 0.99***
43 ± 0.91***
54 ± 1***
% Increase in life span (ILS)
—
***
***
***
Tumor cell count (106 cells/mL)
147 ± 0.21
42 ± 0.6***
28 ± 0.95***
25 ± 0.3***
Percentage of viable cells
94 ± 1
73 ± 1.7***
68 ± 2***
64 ± 2***
Percentage of nonviable cells
6 ± 1
27 ± 2***
32 ± 1***
36 ± 2***
Hb (G%) (12.2–16.2) gm/dL
*
***
RBC (Million/cmm) (7–12.5) × 106/mm3
*
TC (c/mm) (5100–11600)
16900 ± 360
12400 ± 300***
10500 ± 150***
9000 ± 100***
Platelets (/cmm) (160000–410000)
135000 ± 500
150000 ± 430***
195000 ± 600***
210000 ± 550***
Data were expressed as mean ± SD () on day 22 of the experiment. Statistically significant differences are at *, **, ***; ns is the non-significant, as compared with control group.